In preparation for a case, an anaesthetist opened a 20 ml glass vial of propofol and aspirated the propofol into a syringe via a blunt drawing-up needle. Increased resistance was felt with aspiration. On inspection, a shard of glass was found at the tip of the drawing-up needle. The shard was presumed to be from the propofol ampoule, and to have fallen into the solution upon snapping open its glass tip. This illustrative case raises the issue of contamination of drugs by particles introduced during the drawing-up process. It also highlights the possibility that during the drawing-up process, intravenous drugs may become contaminated not just with particles, but with microorganisms on the surface of the particles. In this article, we discuss relevant recent research of the implications of this type of drug contamination. We draw attention to the need for meticulous care in drawing up and administering intravenous drugs during anaesthesia, particularly propofol.
Individual incident reports can provide useful reminders of important aspects of patient care. In a recent report to webAIRS (a de-identified incident reporting system in Australia and New Zealand 1 ), an anaesthetist described an incident in which a glass shard was encountered in a propofol ampoule (these details are presented with the permission of webAIRS). After opening a 20 ml glass ampoule of propofol, the anaesthetist encountered increased resistance while attempting to aspirate the propofol into a syringe using a blunt drawing-up needle. On closer inspection, a shard of glass was found at the tip of the drawing-up needle. The shard was presumed to have originated while snapping open the glass tip of the ampoule, and to have fallen into the ampoule's contents. How should this type of incident be managed? What are the implications if small shards of glass are missed or even injected into the patient? Here we discuss relevant recent research into the implications of this type of drug contamination. We draw attention to the need for meticulous care in drawing up and administering intravenous (IV) drugs during anaesthesia, particularly propofol.
Discussion
It is possible, or even likely, that contamination of glass ampoules by glass particulate matter is quite common during ampoule opening, and this report provides an illustrative example of the problem. The injection of any particulate matter intravenously into patients is clearly not desirable. The case also draws attention to a much wider and more important issue-the possibility that IV drugs may become contaminated not just with particles, but with microorganisms on the surface of the particles, during the process by which the ampoules are opened, drawn up, and administered.
Glass particles are one particular type of contaminant. Several strategies have been suggested to prevent their aspiration, including the use of 5 µm filter needles or straws 2,3 , the use of a vacuum machine to reduce glass particles 4 , or the use of prefilled syringes 5 . However, these strategies have not been widely adopted, in part because filter needles are more expensive than plain needles and may not filter all glass particles 6 , vacuum machines are not practical for everyday use, and prefilled syringes are perceived as expensive. The importance of a modest increase in expense is debatable in the context of the total cost of anaesthesia and surgery, and it is interesting that some institutions in the United States have found it economic to provide a core set of drugs for anaesthesia in prefilled syringes, prepared aseptically in pharmacies, on a daily basis. Prefilled syringes, combined with emerging technologies, have the potential to substantially reduce the contamination of injected drugs and the wider problem of medication error in anaesthesia at the same time 7 .
A cost-neutral way of reducing the size of glass particles being aspirated would be to use smaller gauge plain needles 8 , although this slows down the rate of aspiration and again would not eliminate very small particles. In the past, some glass ampoules were not scored as they are now. Instead a little hacksaw blade was provided with which one could physically create a score mark before breaking the ampoule. We know of no data to show whether this approach was associated with more or less contamination by shards. Today, some drugs are provided in plastic ampoules, which may be less prone to shedding pieces of plastic than glass ampoules are to shedding glass. On the other hand, not all drugs are compatible with plastic, or at least not with all types of plastic, while some drugs are provided in vials with rubber septa. It is theoretically possible to aspirate a core of rubber through the needle used to draw up a drug from such a vial, and inject that into the patient.
Although it is well known that opening a glass ampoule can propel shards of glass back into its contents that can then be aspirated with the drug and injected into a patient [9] [10] [11] [12] [13] , it is less clear whether these particles are harmful. Animal studies have shown formation of granulomas following the infusion of large doses of glass 14 and with IV fluids contaminated with glass and cellulose particles 15 . Pulmonary granulomas have been found in neonates at post mortem following prolonged parenteral nutrition, and were attributed to infusate contamination by particles 16 . In addition, a case of cutaneous silicone granulomas secondary to use of silicone-coated needles has been reported 17 . A firm link between a clinically relevant load of injected particles and acute harm remains to be established.
Material from containers (glass, plastic or rubber) is not the only thing that can contaminate IV drugs. Two studies have recently demonstrated that the injection of IV drugs may also introduce microorganisms into patients, perhaps in about 6% of cases 18, 19 . This contamination is assumed to arise during the process of drawing up drugs into syringes and then injecting the drugs into ports in patients' IV lines.
It seems obvious that the external side of a glass shard may well be one possible vector for such microbiological contamination. The outside of an ampoule is not usually sterile, and neither are the rubber septa on vials. Wiping with a disinfecting solution such as chlorhexidine-in-alcohol may assist in this regard. Hemingway et al 3 compared the growth of microorganisms from the inside neck of 50 opened glass ampoules that had been previously wiped with isopropyl alcohol with that from 50 ampoules that had not been wiped; microorganisms were grown from none of the wiped ampoules and 18% of those that had not been wiped. In a further experiment, these researchers contaminated the external surface of the necks of a further 100 glass ampoules with Staphylococcus aureus. Half of these were subsequently wiped with isopropyl alcohol and all were then opened: again, no growth was obtained from the wiped ampoules, while varying levels of contamination were found in the others.
The issue of potential microbiological contamination is particularly relevant with drugs in which microorganisms can proliferate, notably the short-acting general anaesthetic propofol (2, 6-diisopropylphenol) . The contents of an unopened ampoule of propofol are, of course, sterile but once an ampoule (or other container) has been opened, the lipid emulsion provides nourishment for bacterial growth, so if contamination occurs, microorganisms will proliferate 20 .
The propofol molecule is highly lipophilic. When developed in 1977, a mix of propylene glycol esters and alcohol were used to overcome its lack of miscibility in water 21 . However, this preparation was withdrawn from production after a series of anaphylactic reactions, which were attributed to the propylene glycol component 22 . In 1986, a new oil-in-water, 'macro' emulsion was launched 23 but in the early 1990s an association with postoperative infection was identified 20, [24] [25] [26] [27] . For example, Bennett et al 24 , reported 49 patients who developed infections over a period of 32 months, which were traced to contaminated propofol. The consequences were surprisingly serious: 20 were re-hospitalised, eight had their hospital stay prolonged, 11 needed additional surgical interventions, and two died. The manufacturer responded with an extensive educational program for anaesthesia personnel, and added explicit handling instructions to the product information sheet, emphasising the use of alcohol to decontaminate the neck of ampoules or rubber septa of vials, aseptic technique in drawing up the emulsion, single patient use, and replacement of infusion systems after six hours 27 . A retrospective study by Seeberger et al 28 provided some support for the value of embracing this type of careful practice, but reports of infection persisted. Therefore, in 1996, ethylene-diamine-tetra-acetic acid (EDTA) was added to the formulation to retard the growth of any contaminating microorganisms 29 . Micellar and micro-emulsion formulations which do not utilise lipids are under investigation in animals 30 , but cause more pain on injection than currently used formulations of the drug [31] [32] [33] . Today, propofol can be obtained in ampoules or vials and with or without EDTA; the product currently available in New Zealand does not contain any preservative. It seems then, that contamination by a glass shard could introduce microorganisms into the propofol, a medium in which their rapid proliferation is likely.
It is unclear whether the level of microbial contamination that has been found in ampoules of IV drugs other than propofol is sufficient to cause clinically important infection. A Cochrane review evaluating the use of in-line filters for preventing morbidity and mortality in neonates did not find sufficient evidence for reducing the incidence of mortality or septicaemia from the four eligible studies included in the meta-analysis 34 . However, the context of IV bolus administration in anaesthesia is somewhat different from this setting.
It is likely that the load of injected contaminant would be higher in long, complex cases where often over 30 boluses may be given 35 , and that susceptibility to infection would also be increased after major surgery and prolonged anaesthesia 36, 37 . Patients with implanted joints or heart valves would also be at increased risk. This is an important area for future research but, from the perspective of first principles, it is hard to justify practices that lead to the direct IV injection of particles and/or microorganisms into patients. A lack of evidence in this context is not the same thing as evidence ruling out the possibility of a problem. Thus, even on the strength of what we know today, including incident reports such as this one, it seems prudent to adopt simple practices that reduce the likelihood of microbiological contamination of the drugs we administer intravenously to our patients. If nothing else, we should focus on aseptic techniques in the use of propofol, notably hand hygiene, alcohol wiping of ampoules and rubber septa, and short retention times after drawing up the drug. The point that one should use one ampoule per patient (in line with the policy of the Australian and New Zealand College of Anaesthetists), is taken as given.
Applying these principles to all IV drugs would, at the very least, do no harm and might prevent the development of avoidable postoperative infections.
Conclusion
Anaesthetists may inadvertently inject various forms of contamination into some patients in the process of aspirating and injecting IV drugs. Meticulous attention to aseptic technique is warranted in this process, including appropriate hand hygiene and the use of alcohol wipes for glass ampoules and the rubber septa of vials. Injecting tiny sterile particles alone may not matter, but the inadvertent injection of microorganisms into some patients may have adverse consequences. Therefore, if there is any suggestion of any sort of contamination, the ampoule contents should not be injected into a patient, and the syringe should be discarded. Propofol provides a particularly effective culture medium for bacteria, and syringes of propofol should be prepared and used within the shortest time conveniently possible.
